MFO Ventures

MFO Ventures is a family office established in 2022 by Dr. Eric Moskow to manage his family's assets and create an institutional framework for partnering with investors. The firm's investment strategy is built upon the extensive experience and knowledge gained from Dr. Moskow's prior successful ventures, demonstrating a proven ability to execute and operationalize new enterprises. MFO Ventures focuses exclusively on the healthcare services and healthcare technology sectors, targeting small- and medium-sized companies with EBITDA between $0 and $10 million that exhibit significant growth potential and market disruption capabilities.

The firm specializes in growth equity investments, taking minority equity positions to catalyze company expansion, and actively works with its portfolio companies to identify and execute value-accretive add-on acquisitions. MFO Ventures aims to partner with founder-led and early-stage companies, leveraging its broad network, operational expertise, and flexible capital to support innovators in healthcare delivery. The firm's objective is to contribute to a stronger healthcare system by improving access to care, enhancing quality outcomes, and reducing costs.

MFO Ventures' portfolio includes notable investments such as Arbiter, which is developing an AI system for connecting healthcare, Provista, focused on pharmacy and infusion cost optimization through strategic aggregation and technology, and Forge Health, a company dedicated to transforming behavioral health care. Other investments include ThirdWaveRx, a drug rebate management solutions provider, and Second Wave Delivery Systems. These investments reflect the firm's commitment to supporting innovative approaches and market leaders within its target sectors.

The MFO Ventures team comprises a unique blend of highly experienced healthcare executives, investment professionals, and functional specialists. The core team, which includes co-founders Dr. Eric Moskow, Elliot Moskow, and Jeremy Moskow, has collaborated for over 20 years, bringing deep expertise in healthcare investing, operations, and regulation. This continuity and collective experience underpin the firm's strategic goals, fund direction, and investment focus, enabling them to provide substantial value creation to their portfolio companies.